BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 33782084)

  • 1. Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection.
    Doust JA; Bell KJL; Leeflang MMG; Dinnes J; Lord SJ; Mallett S; van de Wijgert JHHM; Sandberg S; Adeli K; Deeks JJ; Bossuyt PM; Horvath AR
    BMJ; 2021 Mar; 372():n568. PubMed ID: 33782084
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem.
    Cook D
    BMJ; 2020 Dec; 371():m4954. PubMed ID: 33384318
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid coronavirus tests: a guide for the perplexed.
    Guglielmi G
    Nature; 2021 Feb; 590(7845):202-205. PubMed ID: 33564189
    [No Abstract]   [Full Text] [Related]  

  • 4. Lateral flow tests cannot rule out SARS-CoV-2 infection.
    Deeks JJ; Raffle AE
    BMJ; 2020 Dec; 371():m4787. PubMed ID: 33310701
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 re-infection: Diagnostic challenges and proposed diagnostic criteria.
    Raveendran AV
    Diabetes Metab Syndr; 2021; 15(2):645-648. PubMed ID: 33663969
    [No Abstract]   [Full Text] [Related]  

  • 6. [The pitfalls of preventive testing for SARS-CoV-2].
    Wismans LV; Fanoy EB; van Eijck CHJ; van der Eijk AA
    Ned Tijdschr Geneeskd; 2020 Dec; 165():. PubMed ID: 33332034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delays in testing as a source of COVID-19 false-negative results.
    Zimmer R
    Can Fam Physician; 2020 Dec; 66(12):e298-e301. PubMed ID: 33334962
    [No Abstract]   [Full Text] [Related]  

  • 8. One-house one-person testing: Strategical plan to limit COVID-19 spread in stage three in the developing world.
    Ali SME
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):117-118. PubMed ID: 32372726
    [No Abstract]   [Full Text] [Related]  

  • 9. International travel during the COVID-19 pandemic: implications and risks associated with 'travel bubbles'.
    Sharun K; Tiwari R; Natesan S; Yatoo MI; Malik YS; Dhama K
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 33009813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare worker infection with SARS-CoV-2 and test-based return to work.
    Shenoy ES; West LR; Hooper DC; Sheehan RR; Hashimoto D; Boukus ER; Aurora MN; McEvoy DS; Klompas M
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1464-1466. PubMed ID: 32843110
    [No Abstract]   [Full Text] [Related]  

  • 11. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 12. The accelerating COVID-19 epidemic in Sudan.
    Mukhtar MM; Khogali M
    Nat Immunol; 2021 Jul; 22(7):797-798. PubMed ID: 34035525
    [No Abstract]   [Full Text] [Related]  

  • 13. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proactive screening approach for SARS-CoV-2 among healthcare workers.
    Oster Y; Wolf DG; Olshtain-Pops K; Rotstein Z; Schwartz C; Benenson S
    Clin Microbiol Infect; 2021 Jan; 27(1):155-156. PubMed ID: 32822884
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid COVID-19 testing: Speed, quality and cost. Can you have all three?
    Beach LA; Fung AWS; Knauer MJ; Shaw JLV; Taher J
    Clin Biochem; 2021 Sep; 95():13-14. PubMed ID: 34048775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings.
    Khan P; Aufdembrink LM; Engelhart AE
    ACS Synth Biol; 2020 Nov; 9(11):2861-2880. PubMed ID: 32966744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Performance of the Iranian Red Crescent by Launching Testing Centers for the Coronavirus Disease.
    Seddighi H
    Disaster Med Public Health Prep; 2020 Dec; 14(6):e45-e46. PubMed ID: 32438942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing and Interpreting Coronavirus Disease 2019 (COVID-19) Diagnostics: Mathematics, Visual Logistics, and Low Prevalence.
    Kost GJ
    Arch Pathol Lab Med; 2021 Mar; 145(3):291-307. PubMed ID: 32906146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    Kivelä JM; Jarva H; Lappalainen M; Kurkela S
    J Med Virol; 2021 Mar; 93(3):1256-1258. PubMed ID: 33079392
    [No Abstract]   [Full Text] [Related]  

  • 20. Self-testing for SARS-CoV-2: importance of lay communication.
    Coste AT; Egli A; Greub G
    Swiss Med Wkly; 2021 May; 151():w20526. PubMed ID: 34101820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.